Incidence of vasculitis in children in the Czech Republic: 2-Year prospective epidemiology survey

Journal of Rheumatology

Volumn 31, Issue 11, 2004, Pages 2295-2299

  Doležalová, Pavla ^a   Telekešová, Petra ^a   Němcová, Dana ^a   Hoza, Jozef ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Children; Henoch Sch nlein purpura; Incidence; Juvenile dermatomyositis; Kawasaki disease; Primary systemic vasculitis; Systemic lupus erythematosus; Vasculitis

Indexed keywords

ACETYLSALICYLIC ACID; CORTICOSTEROID; IMMUNOGLOBULIN;

ADOLESCENT; ANAPHYLACTOID PURPURA; AORTA ARCH SYNDROME; BRAIN VASCULITIS; CHILD; CLINICAL FEATURE; CLINICAL TRIAL; CONNECTIVE TISSUE DISEASE; CONSULTATION; CORONARY ARTERY DILATATION; CZECH REPUBLIC; DERMATOMYOSITIS; DRUG MEGADOSE; ERYTHEMA NODOSUM; FEMALE; HEALTH SURVEY; HUMAN; JUVENILE RHEUMATOID ARTHRITIS; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MUCHA HABERMANN DISEASE; MUCOCUTANEOUS LYMPH NODE SYNDROME; NEWBORN; PEDIATRICIAN; POLYARTERITIS NODOSA; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUESTIONNAIRE; REVIEW; SHORT COURSE THERAPY; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC VASCULITIS; URTICARIA; VASCULITIS; WEGENER GRANULOMATOSIS;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; CZECH REPUBLIC; DERMATOMYOSITIS; FEMALE; HUMANS; INCIDENCE; INFANT; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; PROSPECTIVE STUDIES; PURPURA, SCHOENLEIN-HENOCH; QUESTIONNAIRES;

EID: 7544225847     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (34)

1. Demography. In: Czech Health Statistics 1997. Prague: 1998.
2. Czech Statistical Office Report; 1992.
3. Gardner-Medwin JMM, Dolezalova P, Cummins C, Southwood TR. Ethnic differences in the incidence of Henoch-Schönlein purpura, Kawasaki disease and rare vasculitides in children. Lancet 2002;360:1197-202.
4. Mills JA, Michel BA, Bloch DA, et al. The American College of Rheumatology 1990 criteria for the classification of Henoch-Schönlein purpura. Arthritis Rheum 1990;33:1114-21.
5. American Heart Association Committee on rheumatic fever, endocarditis and Kawasaki disease. Diagnostic guidelines for Kawasaki disease. Am J Dis Child 1990;144:1218-9.
6. Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-7.
7. Bohan A, Peter JB. Polymyositis and dermatomyositis. N Engl J Med 1975;292:344-7, 403-7.
8. Leavitt RY, Fauci AS, Bloch DA, et al. The American College of Rheumatology 1990 criteria for the classification of Wegener's granulomatosis. Arthritis Rheum 1990;33:1101-7.
9. Jennette JC, Falk RJ, Andrassy K, et al. Nomenclature of systemic vasculitides. Arthritis Rheum 1994;37:187-92.
10. Arend WP, Michel BA, Bloch DA, et al. The American College of Rheumatology 1990 criteria for the classification of Takayasu arteritis. Arthritis Rheum 1990;33:1129-34.
11. Stewart M, Savage JM, Bell B, McCord B. Long term renal prognosis of Henoch-Schönlein purpura in an unselected childhood population. Eur J Pediatr 1988;147:113-5.
12. Nielsen HE. Epidemiology of Schonlein-Henoch purpura. Acta Paediatr Scand 1988;77:125-31.
13. Kaku Y, Nohara K, Honda S. Renal involvement in Henoch-Schönlein purpura: A multivariate analysis of prognostic factors. Kidney Int 1998;53:1755-9.
14. Balmelli C, Laux-End R, Di Rocco D, Carvajal-Busslinger MI, Bianchetti MG. Schoenlein-Henoch purpura: course in 139 children. Schweiz Med Wochenschr 1996;24:293-8.
15. Reinehr T, Bürk G, Berger T, Doeker B, Andler W. Steroids for prophylaxis of Henoch-Schönlein purpura nephropathy? Follow up of 171 patients. Klin Pädiatr 2000;212:99-102.
16. Mollica F, Li Volti S, Garozzo R, Russo G. Effectiveness of early prednisone treatment in preventing the development of nephropathy in anaphylactoid purpura. Eur J Pediatr 1992;151:140-4.
17. Buchanec J, Balanda V, Belakova S, Minarik M, Zibolen M. Incidence of renal complications in Schönlein-Henoch purpura syndrome in dependence of early administration of steroids. Int J Nephrol 1988;20:409-12.
18. Saulsbury FT. Corticosteroid therapy does not prevent nephritis in Henoch-Schönlein purpura. Pediatr Nephrol 1993;7:69-71.
19. Chang RK. Hospitalisations for Kawasaki disease among children in the United States, 1988-1997. Pediatrics 2002;109:1162.
20. Malleson PN, Fung MY, Rosenberg AM. The incidence of pediatric rheumatic diseases: Results from the Canadian Pediatric Rheumatology Association Disease Registry. J Rheumatol 1996;23:1981-7.
21. Yanagawa H, Nakamura Y, Yashiro H, et al. Incidence survey of Kawasaki disease in 1997 and 1998 in Japan. Pediatrics 2001;107:E33.
22. Dhillon R, Newton L, Rudd PT, Hall SM. Management of Kawasaki disease in the British Isles. Arch Dis Child 1993;69:637-8.
23. Pelkonen P, Salo E. Epidemiology of Kawasaki disease. Clin Exp Rheumatol 1994;12 Suppl 10:S83-S85.
24. Schiller B, Fasth A, Bjorkhem G, Elinder G. Kawasaki disease in Sweden: incidence and clinical features. Acta Pediatr 1995;84:769-74.
25. Royle JA, Williams K, Elliot E, et al. Kawasaki disease in Australia, 1993-95. Arch Dis Child 1998;78:33-9.
26. Johnson A, Gordon C, Palmer RG, Bacon PA. The prevalence and incidence of systemic lupus erythematosus in Birmingham, England. Relationship to ethnicity and country of birth. Arthritis Rheum 1995;38:551-8.
27. Oddis CV, Conte CG, Steen VD, Medsger TA Jr. Incidence of polymyositis-dermatomyositis: A 20-year study of hospital diagnosed cases in Allegheny County, PA 1963-1982. J Rheumatol 1990;17:1329-34.
28. Huemer C, Huemer M, Dorner T, et al. Incidence of pediatric rheumatic diseases in a regional population in Austria. J Rheumatol 2001;28:2116-9.
29. Kaipiainen-Seppanen O, Savolainen A. Incidence of chronic juvenile rheumatic diseases in Finland during 1980-1990. Clin Exp Rheumatol 1996;14:441-4.
30. Pelkonen PM, Jalanko HJ, Lantto RK, et al. Incidence of systemic connective tissue diseases in children: A nationwide prospective study in Finland. J Rheumatol 1994;21:2143-6.
31. Fujikawa S, Okuni M. A nationwide surveillance study of rheumatic diseases among Japanese children. Acta Pediatr Jpn 1997;39:242-4.
32. Symmons DPM, Sills JA, Davis SM. The incidence of juvenile dermatomyositis: Results of a nationwide study. Br J Rheumatol 1995;34:732-6.
33. DeNardo BA, Tucker LB, Miller LC, Szer IS, Schaller JG. Demography of a regional pediatric rheumatology patient population. J Rheumatol 1994;21:1553-61.
34. Hanissian AS, Masi AT, Pitner SE, Cape CC, Medsger TA Jr. Polymyositis and dermatomyositis in children: An epidemiological and clinical comparative analysis. J Rheumatol 1982;9:390-4.